SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
[Amendment No. ____]
Filed by the Registrant |X|
Filed by a Party other than the Registrant |_|
Check the appropriate box:
|_| Preliminary Proxy Statement
|_| Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|_| Definitive Proxy Statement
|_| Definitive Additional Materials
|X| Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12
Advanced Nutraceuticals, Inc.
------------------------------------------------
(Name of Registrant as Specified in its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement if other than Registrant)
Payment of Filing Fee (Check the appropriate box):
|X| No fee required.
|_| Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1. Title of each class of securities to which transaction applies:
Not applicable
2. Aggregate number of securities to which transaction applies:
Not applicable
3. Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
Not applicable
4. Proposed maximum aggregate value of transaction:
Not applicable
5. Total fee paid:
Not applicable
|_| Fee paid previously with preliminary materials.
|_| Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.
1. Amount Previously Paid: Not applicable
2. Form, Schedule or Registration Statement No.: Not applicable
3. Filing Party: Not applicable
4. Date Filed: Not applicable
On September 2, 2003, Advanced Nutraceuticals, Inc.
issued the following press release:
Advanced Nutraceuticals, Inc. Announces Board Approval to
---------------------------------------------------------
Seek Reverse Split of Common Stock
----------------------------------
Denver, CO, September 2, 2003 - Advanced Nutraceuticals, Inc. (OTC Bulletin
Board: ANII), announced today that its Board of Directors has authorized the
executive officers of the Company to seek stockholder approval to effect a stock
split of one share to be issued for every 300 shares outstanding as of a record
date to be determined. The amount or formula for payment of fractional shares
will be determined in the future. A meeting of the Company's stockholders is
expected to be scheduled to consider the reverse stock split, following
preparation of the required proxy solicitation materials and other documents for
filing with the SEC, and subsequent distribution to the stockholders.
For additional information contact:
Jeff McGonegal (303) 475-3786 (Email: jmcgonegal@anii.cc) or
Gregory Pusey (303) 722-4008 (Email: gpusey@anii.cc)
- --------------------------------------------------------------------------------
This press release includes "forward looking statements" as defined by the
Securities and Exchange Commission (the "SEC"). All statements, other than
statements of historical fact, included in the press release that address
activities, events or developments that the Company believes or anticipates will
or may occur in the future are forward-looking statements. These statements are
based on certain assumptions made based on experience, expected future
developments and other factors ANII believes are appropriate in the
circumstances. Such statements are subject to a number of assumptions, risks and
uncertainties, many of which are beyond the control of ANII. Investors are
cautioned that any such statements are not guarantees of future performance.
Actual results or developments may differ materially from those projected in the
forward-looking statements as a result of many factors, including adverse
changes in market conditions, fluctuations in sales volumes and problems in
collecting receivables. Furthermore, ANII does not intend (and is not obligated)
to update publicly any forward-looking statements. The contents of this release
should be considered in conjunction with the warnings and cautionary statements
contained in the Company's recent filings with the SEC.
STOCKHOLDERS OF ANII AND OTHER INVESTORS ARE URGED TO READ THE PROXY STATEMENT
IN CONNECTION WITH THE PROPOSED REVERSE STOCK SPLIT BECAUSE IT WILL CONTAIN
IMPORTANT INFORMATION ABOUT ANII, THE REVERSE STOCK SPLIT, THE PERSONS
SOLICITING PROXIES AND THEIR INTERESTS IN THE REVERSE STOCK SPLIT AND RELATED
MATTERS. The proxy statement will be filed with the SEC by ANII. Investors and
security holders may obtain a free copy of the proxy statement (when available)
and other documents filed by ANII with the SEC at the SEC's website at
www.sec.gov. The proxy statement may also be obtained from ANII by directing
such request to Advanced Nutraceuticals, Inc. at 106 S. University Blvd. #14,
Denver, CO 80209, telephone (303) 722-4008. ANII, its directors, executive
officers and certain members of management and employees may be considered
"participants in the solicitation" of proxies from ANII's stockholders in
connection with the reverse stock split. Information regarding such persons and
description of their interests in the reverse stock split is contained in ANII's
filing with the SEC under Rule 14a-12 on January 3, 2003.
CERTAIN INFORMATION CONCERNING PARTICIPANTS
ANII, its directors, executive officers and certain members of management
and employees may be considered "participants in the solicitation" of proxies
from ANII's shareholders in connection with the reverse stock split. The
participants in such solicitation may include the directors of ANII: F. Wayne
Ballenger, Randall D. Humphreys, Gregory Pusey, Pailla M. Reddy and David E.
Welch and the following executive officer of ANII: Jeffrey G. McGonegal (Senior
Vice President - Finance and Secretary).